Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1873956440;56441;56442 chr2:178599686;178599685;178599684chr2:179464413;179464412;179464411
N2AB1709851517;51518;51519 chr2:178599686;178599685;178599684chr2:179464413;179464412;179464411
N2A1617148736;48737;48738 chr2:178599686;178599685;178599684chr2:179464413;179464412;179464411
N2B967429245;29246;29247 chr2:178599686;178599685;178599684chr2:179464413;179464412;179464411
Novex-1979929620;29621;29622 chr2:178599686;178599685;178599684chr2:179464413;179464412;179464411
Novex-2986629821;29822;29823 chr2:178599686;178599685;178599684chr2:179464413;179464412;179464411
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: N
  • RefSeq wild type transcript codon: AAC
  • RefSeq wild type template codon: TTG
  • Domain: Ig-116
  • Domain position: 52
  • Structural Position: 122
  • Q(SASA): 0.2127
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
N/K rs773116579 -0.417 0.996 N 0.507 0.262 0.206339911435 gnomAD-2.1.1 4.03E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.91E-06 0
N/S None None 0.905 N 0.383 0.269 0.198526703765 gnomAD-4.0.0 1.59285E-06 None None None None N None 0 0 None 0 0 None 1.88281E-05 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
N/A 0.3565 ambiguous 0.4961 ambiguous -0.999 Destabilizing 0.994 D 0.566 neutral None None None None N
N/C 0.351 ambiguous 0.4658 ambiguous -0.12 Destabilizing 1.0 D 0.819 deleterious None None None None N
N/D 0.1755 likely_benign 0.2377 benign -0.666 Destabilizing 0.996 D 0.442 neutral D 0.530923316 None None N
N/E 0.3778 ambiguous 0.4782 ambiguous -0.495 Destabilizing 0.997 D 0.505 neutral None None None None N
N/F 0.6885 likely_pathogenic 0.7855 pathogenic -0.623 Destabilizing 1.0 D 0.832 deleterious None None None None N
N/G 0.3703 ambiguous 0.4762 ambiguous -1.397 Destabilizing 0.997 D 0.442 neutral None None None None N
N/H 0.1299 likely_benign 0.1538 benign -0.964 Destabilizing 1.0 D 0.693 prob.neutral N 0.51285763 None None N
N/I 0.3634 ambiguous 0.502 ambiguous 0.044 Stabilizing 0.999 D 0.831 deleterious N 0.496600099 None None N
N/K 0.3501 ambiguous 0.4536 ambiguous -0.105 Destabilizing 0.996 D 0.507 neutral N 0.480454423 None None N
N/L 0.3522 ambiguous 0.4687 ambiguous 0.044 Stabilizing 1.0 D 0.767 deleterious None None None None N
N/M 0.4399 ambiguous 0.5532 ambiguous 0.378 Stabilizing 1.0 D 0.809 deleterious None None None None N
N/P 0.8602 likely_pathogenic 0.9114 pathogenic -0.273 Destabilizing 1.0 D 0.788 deleterious None None None None N
N/Q 0.3197 likely_benign 0.4071 ambiguous -0.714 Destabilizing 1.0 D 0.687 prob.neutral None None None None N
N/R 0.3698 ambiguous 0.4541 ambiguous -0.259 Destabilizing 1.0 D 0.655 neutral None None None None N
N/S 0.0884 likely_benign 0.1109 benign -1.0 Destabilizing 0.905 D 0.383 neutral N 0.454558688 None None N
N/T 0.1567 likely_benign 0.2276 benign -0.611 Destabilizing 0.996 D 0.477 neutral N 0.488191259 None None N
N/V 0.3675 ambiguous 0.504 ambiguous -0.273 Destabilizing 1.0 D 0.803 deleterious None None None None N
N/W 0.8147 likely_pathogenic 0.8668 pathogenic -0.361 Destabilizing 1.0 D 0.791 deleterious None None None None N
N/Y 0.2433 likely_benign 0.3268 benign -0.109 Destabilizing 1.0 D 0.818 deleterious D 0.536811925 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.